MetLife Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.05M | Sell |
10,062
-391
| -4% | -$118K | 0.02% | 790 |
|
2025
Q1 | $3.46M | Sell |
10,453
-365
| -3% | -$121K | 0.02% | 796 |
|
2024
Q4 | $3.34M | Buy |
10,818
+695
| +7% | +$214K | 0.02% | 782 |
|
2024
Q3 | $2.15M | Hold |
10,123
| – | – | 0.01% | 982 |
|
2024
Q2 | $2.84M | Buy |
10,123
+2,537
| +33% | +$711K | 0.02% | 811 |
|
2024
Q1 | $2.03M | Sell |
7,586
-172
| -2% | -$45.9K | 0.01% | 942 |
|
2023
Q4 | $1.8M | Buy |
7,758
+581
| +8% | +$134K | 0.01% | 988 |
|
2023
Q3 | $1.05M | Hold |
7,177
| – | – | 0.01% | 1204 |
|
2023
Q2 | $1.66M | Buy |
7,177
+495
| +7% | +$114K | 0.01% | 1007 |
|
2023
Q1 | $1.62M | Hold |
6,682
| – | – | 0.01% | 991 |
|
2022
Q4 | $1.94M | Hold |
6,682
| – | – | 0.01% | 920 |
|
2022
Q3 | $434K | Hold |
6,682
| – | – | ﹤0.01% | 1743 |
|
2022
Q2 | $478K | Hold |
6,682
| – | – | ﹤0.01% | 1700 |
|
2022
Q1 | $656K | Buy |
6,682
+2,468
| +59% | +$242K | ﹤0.01% | 1610 |
|
2021
Q4 | $357K | Buy |
4,214
+527
| +14% | +$44.7K | ﹤0.01% | 1693 |
|
2021
Q3 | $294K | Hold |
3,687
| – | – | ﹤0.01% | 1831 |
|
2021
Q2 | $359K | Hold |
3,687
| – | – | ﹤0.01% | 1776 |
|
2021
Q1 | $431K | Hold |
3,687
| – | – | ﹤0.01% | 1616 |
|
2020
Q4 | $410K | Hold |
3,687
| – | – | ﹤0.01% | 1586 |
|
2020
Q3 | $438K | Hold |
3,687
| – | – | ﹤0.01% | 1434 |
|
2020
Q2 | $418K | Hold |
3,687
| – | – | ﹤0.01% | 1484 |
|
2020
Q1 | $246K | Hold |
3,687
| – | – | ﹤0.01% | 1580 |
|
2019
Q4 | $336K | Hold |
3,687
| – | – | ﹤0.01% | 1672 |
|
2019
Q3 | $318K | Hold |
3,687
| – | – | ﹤0.01% | 1676 |
|
2019
Q2 | $386K | Buy |
3,687
+564
| +18% | +$59.1K | ﹤0.01% | 1630 |
|
2019
Q1 | $391K | Hold |
3,123
| – | – | ﹤0.01% | 1600 |
|
2018
Q4 | $352K | Hold |
3,123
| – | – | ﹤0.01% | 1582 |
|
2018
Q3 | $669K | Buy |
3,123
+422
| +16% | +$90.4K | 0.01% | 1349 |
|
2018
Q2 | $755K | Buy |
2,701
+586
| +28% | +$164K | 0.01% | 1164 |
|
2018
Q1 | $247K | Hold |
2,115
| – | – | ﹤0.01% | 1774 |
|
2017
Q4 | $194K | Buy |
+2,115
| New | +$194K | ﹤0.01% | 1943 |
|